Skip to main content

ALAmax CR 120T

(No reviews yet)
$116.99

Controlled-Release Alpha-Lipoic Acid

Card Subtitle:
Controlled-Release Alpha-Lipoic Acid
Product Subtitle:
Controlled-Release Alpha-Lipoic Acid
SKU:
10077
UPC:
871149004392

Product Overview

ALAmax™ CR

ALAmax™ CR is a whole-body, multifunctional antioxidant that helps to maintain healthy, well-functioning cells. ALAmax CR is designed to neutralize free radicals. ALAmax CR has the ability to destroy free radicals in both the water-based and lipid-based portion of cells, making it the ideal whole-body antioxidant. In addition, ALAmax CR helps the body synthesize glutathione, the body’s own master detoxifier. ALAmax CR also “recharges” other important antioxidants, such as vitamins C and E, and CoQ10, giving them the ability to continue fighting free radicals for extended periods of time. In addition, biotin supports the function of alpha-lipoic acid in regulating glucose metabolism.*

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Suggested Use

Take one tablet 30 minutes before breakfast and one tablet 30 minutes before dinner, or as directed by your healthcare professional.

Consult your healthcare professional prior to use. Individuals taking medication should discuss potential interactions with their healthcare professional. Do not use if tamper seal is damaged.

Precautions

If you are pregnant or nursing, consult your physician before taking this product.

Supplement Facts

Serving Size: 1 Tablet
Servings Per Container: 120

  Amount Per Serving % Daily Value
Biotin 450 mcg 1,500%
Alpha-Lipoic Acid 600 mg **
**Daily Value not established.

Other Ingredients: Hydroxypropyl methyl cellulose, magnesium stearate, microcrystalline cellulose, hydroxypropyl cellulose, dicalcium phosphate, silica, and coating (hydroxypropyl methyl cellulose and medium-chain triglycerides).

Made in a GMP compliant facility.

Disclaimer

Reviews

No reviews yet.